UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years

European journal of clinical pharmacology, 2009-06, Vol.65 (10), p.989-998

2009

Volltextzugriff (PDF)

Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study

Molecular pharmaceutics, 2013-05, Vol.10 (5), p.1533-1541

2013

Volltextzugriff (PDF)

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Blood, 2012-01, Vol.119 (2), p.612-618

2012

Volltextzugriff (PDF)

In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-01, Vol.13 (1), p.2-8

2007

Volltextzugriff (PDF)

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

British journal of clinical pharmacology, 2005-06, Vol.59 (6), p.691-704

Björkman, Sven

2005

Volltextzugriff (PDF)

Intellectual Collaboration with the Third Reich: Treason or Reason?

2019

Volltextzugriff (PDF)

Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans

European journal of pharmacology, 2008-03, Vol.581 (3), p.290-295

2008

Volltextzugriff (PDF)

Reduction and lumping of physiologically based pharmacokinetic models: Prediction of the disposition of fentanyl and pethidine in humans by successively simplified models

Journal of pharmacokinetics and pharmacodynamics, 2003-08, Vol.30 (4), p.285-307

BJÖRKMAN, Sven

2003

Volltextzugriff (PDF)

Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring

Blood, 2010-11, Vol.116 (21), p.1416-1416

2010

Volltextzugriff (PDF)

Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children : How accurate are available scaling methods?

Clinical pharmacokinetics, 2006, Vol.45 (1), p.1-11

Bjorkman, Sven

2006

Volltextzugriff (PDF)

Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (4), p.597-605

BJÖRKMAN, S.

2010

Volltextzugriff (PDF)

Pharmacokinetics of PDFIX and RFIX concentrates - implications for prophylaxis and on-demand therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2013, Vol.19 (S2), p.7

Björkman, Sven

2013

Volltextzugriff (PDF)

Methods for individualising factor VIII dosing in prophylaxis

European journal of haematology, 2014-08, Vol.93 (s76), p.16-20

2014

Volltextzugriff (PDF)

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A

Blood, 2009-11, Vol.114 (22), p.3492-3492

2009

Volltextzugriff (PDF)

Oxymorphone Active Uptake at the Blood–Brain Barrier and Population Modeling of its Pharmacokinetic–Pharmacodynamic Relationship

Journal of pharmaceutical sciences, 2013-09, Vol.102 (9), p.3320-3331

2013

Volltextzugriff (PDF)

Population pharmacokinetics of recombinant factor IX: implications for dose tailoring

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.753-757

Bjorkman, S

2013

Volltextzugriff (PDF)

Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo

Journal of pharmaceutical sciences, 2011-09, Vol.100 (9), p.3912-3923

2011

Volltextzugriff (PDF)

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.2-10

2011

Volltextzugriff (PDF)

Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis

European journal of clinical pharmacology, 2012-06, Vol.68 (6), p.969-977

2012

Volltextzugriff (PDF)

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia

Blood, 2008-11, Vol.112 (11), p.1222-1222

2008

Volltextzugriff (PDF)

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

Journal of thrombosis and haemostasis, 2009-03, Vol.7 (3), p.413-420

2009

Volltextzugriff (PDF)

Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-11, Vol.19 (6), p.808-813

Bjorkman, S

2013

Volltextzugriff (PDF)

JEAN-CHRISTOPHE ABRAMOVICI, Encre de sang: Sade écrivain. L’Europe des Lumières, sous la direction de Michel Delon et Jacques Berchtold, 22 (Paris: Classiques Garnier, 2013). 164 pp

Sjuttonhundratal : sällskapet för 1700-talsstudier, 2015-11, Vol.12, p.248-250

Björkman, Sven

2015

Volltextzugriff (PDF)

A Whole‐Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat

Basic & clinical pharmacology & toxicology, 2018-10, Vol.123 (4), p.407-422

2018

Volltextzugriff (PDF)

Intravenous Formulations of the Enantiomers of Thalidomide: Pharmacokinetic and Initial Pharmacodynamic Characterization in Man

Journal of pharmacy and pharmacology, 2000-07, Vol.52 (7), p.807-817

2000

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(204)

Publikationsform

Artikel
(195)
Buchkapitel
(20)
Reviews
(20)
Bücher
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years

Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

Intellectual Collaboration with the Third Reich: Treason or Reason?

Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans

Reduction and lumping of physiologically based pharmacokinetic models: Prediction of the disposition of fentanyl and pethidine in humans by successively simplified models

Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring

Prediction of cytochrome P450-mediated hepatic drug clearance in neonates, infants and children : How accurate are available scaling methods?

Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A

Pharmacokinetics of PDFIX and RFIX concentrates - implications for prophylaxis and on-demand therapy

Methods for individualising factor VIII dosing in prophylaxis

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A

Oxymorphone Active Uptake at the Blood–Brain Barrier and Population Modeling of its Pharmacokinetic–Pharmacodynamic Relationship

Population pharmacokinetics of recombinant factor IX: implications for dose tailoring

Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy

JEAN-CHRISTOPHE ABRAMOVICI, Encre de sang: Sade écrivain. L’Europe des Lumières, sous la direction de Michel Delon et Jacques Berchtold, 22 (Paris: Classiques Garnier, 2013). 164 pp

A Whole‐Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat

Intravenous Formulations of the Enantiomers of Thalidomide: Pharmacokinetic and Initial Pharmacodynamic Characterization in Man

Suchergebnisse filtern